Dr. Reddy's Laboratories Share Price

Mid Cap | Pharmaceuticals and health care | NSE: DRREDDY | BSE: 500124

₹1,236.30 image16.30 (1.34 %)

Last Updated: 15 May 2025 03:59 PM

Technicalsimage BULLISHimage

Overview

Open (₹) 1,214.00

High (₹) 1,239.80

Low (₹) 1,200.20

Prev. Close (₹) 1,220.00

Volume 20,53,550

VWAP (₹) 1,182.01

ROCE (%) 21.81

Industry P/E 45.08

TTM P/E 19.21

P/B Ratio 3.07

Market Cap (₹) Cr.1,03,163.72

Dividend Yield (%)--

EPS (₹) 64.13

ROE15.94%

Sales Growth (%) 16.54

Profit Growth (%)2.52

Day Range

1,239.801,239.80

L
H

52 Week Range

1,025.901,420.20

L
H

Historical Returns

Returns (6M)

3.58 %

Returns (1Y)

5.66 %

Returns (3Y)

58.34 %

Returns (5Y)

68.01 %

Returns (6M)

3.58 %

Returns (1Y)

5.66 %

Returns (3Y)

58.34 %

Returns (5Y)

68.01 %

SWOT Analysis

  • Company with Low Debt
  • Increasing Annual Revenue for Past 2 Years
  • Growth in Net Profit Margin (QoQ)
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Bullish MACD crossover (12,6,9) indicates potential upward price movement.
  • Positive ROC (9) indicates upward momentum.
  • Strong trend indicated by ADX above 25.
  • Price above the pivot point indicates bullish sentiment.
  • Price above EMA and SMA (50) indicates bullish momentum.

Technicals
info_icon

Technical Rating

Trendimage  BULLISH
Moving Averages
Technical Indicators
Bullish
Bearish

RSI 54.32

MFI 71.60

ATR 31.13

Commodity Channel Index 65.58

ROC125 -9.81

ROC21 1.78

Williams %R -18.54

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current1,194.661,206.431,218.061,183.031,171.261,159.631,147.86
Week Ago1,203.641,232.471,254.441,181.671,152.841,130.871,102.04
Month Ago1,156.801,163.601,174.501,145.901,139.101,128.201,121.40

EMA & SMA
info_icon

1236.30

Current Price

EMA & SMApin

Bullish Moving Averages

18

Bearish Moving Averages

2

5 Day 1180.44


9 Day 1182.61


10 Day 1178.56


12 Day 1163.44


14 Day 1157.13

20 Day 1154.52


26 Day 1162.78


50 Day 1157.84


100 Day 1220.51


200 Day 1272.17

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell14th Nov, 2022₹4,539.451,80,717NSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy14th Nov, 2022₹4,539.451,80,717NSE
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell3rd Nov, 2022₹4,555.651,80,718NSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy3rd Nov, 2022₹4,555.651,80,718NSE
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell3rd Oct, 2022₹4,335.701,49,492NSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy3rd Oct, 2022₹4,335.701,49,492NSE
ISHARES INDIA MAURITIUS COblockSell8th Aug, 2022₹4,156.8519,329NSE
ISHARES INDIA INDEX MAURITIUS COMPANYblockSell8th Aug, 2022₹4,156.851,37,595NSE
ISHARES MSCI INDIA ETFblockBuy8th Aug, 2022₹4,156.851,37,595NSE
ISHARES INDIA 50 ETFblockBuy8th Aug, 2022₹4,156.8519,329NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
26th Sept, 2024Vincent ColicchioAcquisition₹6,553.001,594NSE
26th Sept, 2024Anjum SwaroopAcquisition₹6,553.001,412NSE
26th Sept, 2024C SwaminathanDisposal₹6,651.411,700NSE
4th Sept, 2024Bryan DixonAcquisition₹6,914.00150NSE
4th Sept, 2024Milan KalawadiaAcquisition₹6,914.00814NSE
4th Sept, 2024Subba IntaAcquisition₹6,914.00704NSE
4th Sept, 2024C SwaminathanAcquisition₹6,914.721,250NSE
4th Sept, 2024Juan Carlos AlvarezAcquisition₹6,914.00145NSE
4th Sept, 2024Sanjay ChoubeyAcquisition₹6,914.00215NSE
4th Sept, 2024Tricia WetzelAcquisition₹6,802.78594NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
27th Jul, 2024Stock Split from Rs. 5/- to Re. 1/-28th Oct, 202428th Oct, 2024
7th May, 2024Rs.40.0000 per share(800%)Final Dividend16th Jul, 20241st Jan, 1970
10th May, 2023Rs.40.0000 per share(800%)Final Dividend11th Jul, 20231st Jan, 1970
19th May, 2022Rs.30.0000 per share(600%)Final Dividend11th Jul, 20221st Jan, 1970

Announcements

DateSourceDetail
9th May, 2025BSE IndiaQ4 & FY 2025 Audited Financial results presentation
9th May, 2025BSE IndiaIncorporation of Step down Wholly-owned Subsidiary
9th May, 2025BSE IndiaAudited Financial results for the quarter and year ended March 31, 2025
9th May, 2025BSE IndiaGrant of employee stock options
9th May, 2025BSE IndiaAppointment of Secretarial Auditor of the Company
9th May, 2025BSE India41st Annual General Meeting (AGM) of the members of the Company scheduled to be held on Thursday, July 24, 2025.
9th May, 2025BSE IndiaRecommendation of final dividend
9th May, 2025BSE IndiaRecord date for purpose of determining the members eligible to receive the final dividend for the financial year ended March 31, 2025 is fixed as July 10, 2025
9th May, 2025BSE IndiaRecommendation of final dividend
9th May, 2025BSE IndiaRe-appointment of Mr. G V Prasad, Whole-Time Director designated as Co-Chairman & Managing Director

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Audited Results, Dividend & OthersTo consider other business matters.25th Mar, 20259th May, 2025
Quarterly Results--24th Dec, 202423rd Jan, 2025
Quarterly Results--1st Oct, 20245th Nov, 2024
Quarterly Results & Stock Split--24th Jul, 202427th Jul, 2024
Audited Results & Final Dividend--26th Mar, 20247th May, 2024
Quarterly Results--22nd Dec, 202330th Jan, 2024
Quarterly Results--26th Sept, 202327th Oct, 2023
Quarterly Results--11th Jul, 202326th Jul, 2023
Audited Results & Final Dividend--24th Mar, 202310th May, 2023
Quarterly Results--28th Dec, 202225th Jan, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameMar, 2025Dec, 2024Dec, 2023Dec, 2022Dec, 2021
Promoter Group26.64%26.64%26.65%26.7%26.72%
Foreign Institutions +25.75%26.85%28.62%27.29%27.42%
Domestic Institutions +37.17%36.12%33.98%33.91%22.29%
Government0%0%0%0%0%
Public10.15%10.23%10.57%11.85%23.29%
Others0.29%0.16%0.18%0.25%0.28%

About Dr. Reddy's Laboratories

Dr. Reddy's Laboratories is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company’s Total Operating Revenue is Rs. 23115.40 Cr. and Equity Capital is Rs. 83.40 Cr. for the Year ended 31/03/2025.

Parent Organisation

Reddy Group

Founded

1984

Managing Director

-- --

NSE Symbol

DRREDDY

Dr. Reddy's Laboratories Management

NameDesignation
Mr. K Satish ReddyChairman
Mr. G V PrasadCo-Chairman & Manag. Director
Dr. Claudio AlbrechtIndependent Director
Ms. Kalpana MorpariaIndependent Director
Mr. Leo PuriIndependent Director
Ms. Shikha SharmaIndependent Director
Mr. Sanjiv MehtaIndependent Director
Mr. Arun M KumarIndependent Director
Dr. K P KrishnanIndependent Director
Ms. Penny WanIndependent Director
Dr. Alpna SethIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,38,934.34₹1,740.10 image
₹1,708.20(1.87%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,62,042.02₹6,214.50 image
₹6,215.50(-0.02%)
₹3,725.550 - ₹6,448.750
Cipla₹1,23,213.62₹1,502.20 image
₹1,494.80(0.50%)
₹1,310.050 - ₹1,702.000
Torrent Pharmaceuticals₹1,10,170.76₹3,265.00 image
₹3,244.90(0.62%)
₹2,513.050 - ₹3,589.950
Dr. Reddy's Laboratories₹98,707.73₹1,236.30 image
₹1,220.00(1.34%)
₹1,025.900 - ₹1,420.200

FAQs on Dr. Reddy's Laboratories

What is the share price of Dr. Reddy's Laboratories?

The share price of Dr. Reddy's Laboratories on 15th May, 2025 is ₹ 1,236.30.

What is 52W high and 52W low share price of Dr. Reddy's Laboratories?

The highest and lowest 52W share prices of Dr. Reddy's Laboratories are ₹ 1420.200 and ₹ 1025.900

What is the market cap of Dr. Reddy's Laboratories?

The market capitalization of Dr. Reddy's Laboratories as of 15th May, 2025 is ₹ 1,03,163.72 Crores

What is the P/E ratio of Dr. Reddy's Laboratories?

The current P/E ratio of Dr. Reddy's Laboratories as of 15th May, 2025 is 45.08

What is the PB ratio of Dr. Reddy's Laboratories?

The PB ratio of Dr. Reddy's Laboratories as of 15th May, 2025 is 3.07

Top Gainers

₹150.10image

₹125.30 (0.20%)

₹108.60image

₹90.50 (0.20%)

₹110.78image

₹92.32 (0.20%)

₹14.37image

₹11.98 (0.20%)

Top Losers

₹269.00image

₹316.50 (-0.15%)

₹392.90image

₹436.40 (-0.10%)

₹0.50image

₹0.62 (-0.19%)

₹664.60image

₹771.65 (-0.14%)

Market Indices

Sensex

₹80,501.99image

₹80,242.24 (0.00%)

Source : Dion Global Solutions Limited